News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-21 5:2:20 am Acumen Pharmaceuticals to Present Deeper Insights, Including Fluid Biomarker Data for Sabirnetug (ACU193), During Emerging Science Session at the American Academy of Neurology Annual Meeting GlobeNewsWire
2024-03-19 1:0:0 pm Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024 GlobeNewswire
2024-03-18 7:31:44 am 15 Best Anti-Aging Foods for Youthful Skin Insider Monkey
2024-03-12 1:0:0 pm Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days GlobeNewswire
2024-03-08 5:50:0 am Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting GlobeNewswire
2024-02-29 6:40:12 am Has Acumen Pharmaceuticals (ABOS) Outpaced Other Medical Stocks This Year? Zacks
2024-02-24 5:10:34 am Institutional investors own a significant stake of 42% in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Simply Wall St.
2024-02-21 5:0:0 am Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting GlobeNewswire
2024-02-01 4:0:0 am Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information